• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性肝胆恶性肿瘤的移植及桥接手术适应症]

[Indications for transplantation and bridging procedures for primary hepatobiliary malignancies].

作者信息

Mittler J, Heinrich S, Lang H

机构信息

Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsmedizin Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland.

出版信息

Chirurg. 2018 Nov;89(11):865-871. doi: 10.1007/s00104-018-0733-z.

DOI:10.1007/s00104-018-0733-z
PMID:30238348
Abstract

Primary hepatobiliary malignancies are hepatocellular carcinoma, cholangiocarcinoma and the rare hepatocellular cholangiocarcinoma (mixed tumor). The indications for liver transplantation and the oncological prognosis differ considerably between these tumor entities. Treatment and decision making for these tumors are often complicated by an underlying chronic liver disease. The aim of this review is to delineate the indications for transplantation and bridging therapies for each cancer entity as well as to highlight some aspects pertinent to transplantation, such as the principles of organ allocation.

摘要

原发性肝胆恶性肿瘤包括肝细胞癌、胆管癌以及罕见的肝细胞胆管癌(混合性肿瘤)。这些肿瘤实体在肝移植指征和肿瘤学预后方面存在显著差异。这些肿瘤的治疗和决策常常因潜在的慢性肝病而变得复杂。本综述的目的是阐明每种癌症实体的移植指征和桥接治疗方法,并强调与移植相关的一些方面,如器官分配原则。

相似文献

1
[Indications for transplantation and bridging procedures for primary hepatobiliary malignancies].[原发性肝胆恶性肿瘤的移植及桥接手术适应症]
Chirurg. 2018 Nov;89(11):865-871. doi: 10.1007/s00104-018-0733-z.
2
Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.等待肝移植的肝细胞癌和胆管癌患者的治疗选择
Clin Liver Dis. 2017 May;21(2):231-251. doi: 10.1016/j.cld.2016.12.002.
3
Hepatobiliary malignancy.肝胆恶性肿瘤
Clin Liver Dis. 1998 May;2(2):437-49, xi-xii. doi: 10.1016/s1089-3261(05)70017-9.
4
Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.肝细胞癌与肝内胆管癌在肝脏两叶同步发生。
Turk J Gastroenterol. 2014 Apr;25(2):209-11. doi: 10.5152/tjg.2014.6188.
5
[Regional therapy of liver tumors].[肝脏肿瘤的区域治疗]
Internist (Berl). 2007 Jan;48(1):40-5. doi: 10.1007/s00108-006-1771-z.
6
Hepatobiliary tumours.肝胆肿瘤
Practitioner. 2001 Aug;245(1625):668-74.
7
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.用于肝胆恶性肿瘤的肝移植:“移植肿瘤学”的新时代已经开启。
Surg Today. 2017 Apr;47(4):403-415. doi: 10.1007/s00595-016-1337-1. Epub 2016 Apr 29.
8
[Primary Liver Cancers - Hepatocellular Carcinoma and Cholangiocarcinoma].[原发性肝癌——肝细胞癌和胆管癌]
Ther Umsch. 2021;78(10):585-588. doi: 10.1024/0040-5930/a001314.
9
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.肝细胞-胆管细胞癌:放射科医生需要了解的双表型肝癌相关知识。
Abdom Imaging. 2014 Apr;39(2):310-22. doi: 10.1007/s00261-013-0069-6.
10
Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment.肝胆癌:诊断、发病机制和治疗的进展。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221097203. doi: 10.1177/15330338221097203.

本文引用的文献

1
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
2
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.新辅助治疗后局部进展期肝内胆管细胞癌行肝移植治疗:一项前瞻性病例系列研究。
Lancet Gastroenterol Hepatol. 2018 May;3(5):337-348. doi: 10.1016/S2468-1253(18)30045-1. Epub 2018 Mar 13.
3
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.
cHCC-CCA:具有肝细胞和胆管细胞分化的原发性肝癌的共识术语。
Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.
4
Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation.原位肝移植前桥接治疗在肝细胞癌治疗中的有效性
J Gastrointest Oncol. 2017 Dec;8(6):1051-1055. doi: 10.21037/jgo.2017.08.11.
5
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究:1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
6
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.米兰标准内肝细胞癌患者肝移植前桥接局部区域治疗的影响:来自美国多中心肝癌移植联盟的3601例患者分析
Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.
7
[Selective internal radioembolization in nonresectable hepatocellular carcinoma].[不可切除肝细胞癌的选择性肝内放射栓塞术]
Chirurg. 2016 Nov;87(11):956-963. doi: 10.1007/s00104-016-0259-1.
8
Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.仅对肝门部胆管癌肝移植患者进行严格筛选与生存率提高相关。
PLoS One. 2016 Jun 8;11(6):e0156127. doi: 10.1371/journal.pone.0156127. eCollection 2016.
9
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?早期肝细胞癌的挽救性肝移植与原位肝移植:两种策略的结果相似吗?
Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442.
10
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.总肿瘤体积和甲胎蛋白联合用于选择肝癌肝移植候选者:前瞻性验证。
Hepatology. 2015 Jul;62(1):158-65. doi: 10.1002/hep.27787. Epub 2015 Apr 22.